These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9369081)

  • 1. [Coronary circulation-derived plasma in patients with vascular restenosis stimulates the growth of coronary artery smooth muscle cells in culture].
    Okamoto Y; Uemura S; Yamamoto H; Dohi K; Nakano H
    Rinsho Byori; 1997 Oct; 45(10):1008-12. PubMed ID: 9369081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study].
    Inoue K; Nakamura N; Kakio T; Suyama H; Tanaka S; Goto Y; Nakazawa Y; Yamamoto Y; Nagamatsu T
    J Cardiol; 1994; 24(4):279-91. PubMed ID: 8057240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
    Bauriedel G
    Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gene therapy for the treatment of restenosis after coronary angioplasty].
    Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
    Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization.
    Wahl A; Billinger M; Fleisch M; Meier B; Seiler C
    Eur Heart J; 2000 Nov; 21(21):1776-84. PubMed ID: 11052842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
    Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
    Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.
    Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fontanelli A; Monici Preti PA; Repetto S; Raffaghello S
    Clin Trials Metaanal; 1994 Apr; 29(1):31-40. PubMed ID: 10150183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis.
    Inoue T; Sakai Y; Fujito T; Hoshi K; Hayashi T; Takayanagi K; Morooka S
    Thromb Haemost; 1998 Jan; 79(1):54-8. PubMed ID: 9459323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of restenosis after percutaneous transluminal coronary angioplasty using coronary flow reserve. Kansai Doppler Guide Wire Study Group].
    Toda I; Teragaki M; Nishida Y; Kobayashi Y; Shimada K; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Cardiol; 2000 Mar; 35(3):165-73. PubMed ID: 10808423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and restenosis after percutaneous coronary intervention.
    Mahanonda N; Leowattana W; Kangkagate C; Lolekha P; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S636-44. PubMed ID: 12002904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris.
    Yang A; Pizzulli L; Lüderitz B
    Thromb Res; 2006; 117(4):371-7. PubMed ID: 15935453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth muscle cell migration promoting activity of plasma predicts restenosis in patients with peripheral arterial occlusive disease undergoing angioplasty.
    Roller RE; Janisch S; Kvas E; Schnedl WJ; Binder BR; Wojta J; Korninger C
    Thromb Haemost; 2000 Dec; 84(6):1113-6. PubMed ID: 11154122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Restenosis after percutaneous coronary angioplasty--cause, prevention strategies].
    Szyguła J; Puzio B; Poloński L
    Wiad Lek; 1998; 51(1-2):76-81. PubMed ID: 9608836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.